Definition and Characteristics
Deficiencies of the enzymes carnitine palmitoyltransferase (CPT) I and II are autosomal recessive diseases due to impaired beta-oxidation of long-chain fatty-acids. Transport of long-chain fatty-acid into mitochondria depends on the carnitine shuttle consisting of CPT I and II and acylcarnitine translocase (Fig. 1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bonnefont PF, Djouadi F, Prip-Buus C, Gobin S, Munnich A, Bastin J (2004) Mol Aspects Med 25:495–520
Deschauer M, Wieser T, Zierz S (2005) Arch Neurol 62:37–41
Zierz S, Engel AG (1985) Eur J Biochem 149:207–214
Isackson PJ, Bennett MJ, Vladutiu GD (2006) Mol Genet Metab 89:323–331
Rufer AC, Thoma R, Benz J, Stihle M, Gsell B, De Roo E, Banner DW, Mueller F, Chomienne O, Hennig M (2006) Structure 14:713–723
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag GmbH Berlin Heidelberg
About this entry
Cite this entry
Deschauer, M., Zierz, S. (2009). Carnitine Palmitoyltransferase II Deficiency. In: Lang, F. (eds) Encyclopedia of Molecular Mechanisms of Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-29676-8_421
Download citation
DOI: https://doi.org/10.1007/978-3-540-29676-8_421
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-67136-7
Online ISBN: 978-3-540-29676-8
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences